Latest news
Unpacking the Investment Value of AbbVie and Abbott in 2026 - NAI500NAI500 · Sat, 08 Aug 2026 10:35:10 GMTAbbVie (ABBV) Stock May Be 45% Below Fair Value As Rinvoq Expands In Europe - simplywall.stsimplywall.st · Sat, 08 Aug 2026 07:46:03 GMTAbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026? - The Motley FoolThe Motley Fool · Fri, 07 Aug 2026 21:24:00 GMTAbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's Changed - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 20:14:43 GMTAbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial - TipRanksTipRanks · Fri, 07 Aug 2026 17:02:38 GMTAbbVie (ABBV) Q1 2026 Earnings Call Transcript - FortuneFortune · Fri, 07 Aug 2026 10:06:33 GMTThe 5 Most Interesting Analyst Questions From AbbVie’s Q2 Earnings Call - StockStoryStockStory · Fri, 07 Aug 2026 08:56:38 GMTMedicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts - STATSTAT · Thu, 06 Aug 2026 19:04:45 GMT